Medicine
Cefdinir 250 mg/5 mL powder for oral suspension
Cefdinir 250 mg/5 mL powder for oral suspension is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store dry powder and reconstituted suspension at 20° to 25°C (68° to 77°F),.
Key facts
- Active ingredient (INN)
- Cefdinir
- Brand
- Sold under the generic name
- Strength
- 250 mg/5 mL
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 100 mL, 60 mL, 1 bottle and 26 more
- Manufacturers
- Ascend LaboratoriesIndiaAurobindo PharmaIndiaLupinIndiaA-S Medication SolutionsProficient RxDirect_RxAsclemedNuCare Pharmaceuticals,IncPreferred PharmaceuticalsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store dry powder and reconstituted suspension at 20° to 25°C (68° to 77°F),.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DD15 Cefdinir
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 May 2007
- Identifiers
- RxCUI 309054, 476576DailyMed set ID 982d0f53-20bc-1cb4-e053-2995a90ad33c, 0eeac6df-bad7-413e-8b41-0660f3a99373, 42a2d8f5-12bc-4745-b9d4-e69ba6c66647 +17NDC 72189-043, 50090-3725, 50090-8104 +19Application ANDA065259, ANDA065332, ANDA210534 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 mL in 1 bottle | 67877-548-88 | Ascend LaboratoriesIndia | 20 February 2021 |
| 60 mL in 1 bottle | 67877-548-98 | Ascend LaboratoriesIndia | 20 February 2021 |
| 1 bottle in 1 carton / 100 mL in 1 bottle | 65862-219-01 | Aurobindo PharmaIndia | 14 December 2007 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 65862-219-60 | Aurobindo PharmaIndia | 14 December 2007 |
| 60 mL in 1 bottle | 68180-723-04 | LupinIndia | 22 May 2020 |
| 100 mL in 1 bottle | 68180-723-05 | LupinIndia | 22 May 2020 |
| 60 mL in 1 bottle | 0093-4137-64 | Teva Pharmaceuticals | 8 May 2007 |
| 100 mL in 1 bottle | 0093-4137-73 | Teva Pharmaceuticals | 8 May 2007 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 50090-2735-0 | A-S Medication Solutions | 29 December 2016 |
| 100 mL in 1 bottle | 50090-3723-0 | A-S Medication Solutions | 25 October 2018 |
| 60 mL in 1 bottle | 50090-3725-0 | A-S Medication Solutions | 25 October 2018 |
| 60 mL in 1 bottle | 50090-5811-0 | A-S Medication Solutions | 18 October 2021 |
| 60 mL in 1 bottle | 50090-6171-0 | A-S Medication Solutions | 14 October 2022 |
| 100 mL in 1 bottle | 50090-8104-0 | A-S Medication Solutions | 7 October 2026 |
| 5 mL in 1 bottle | 72189-043-32 | Direct RX | 25 November 2019 |
| 60 mL in 1 bottle | 72189-186-32 | Direct RX | 12 April 2021 |
| 100 mL in 1 bottle | 72189-259-32 | Direct RX | 13 September 2021 |
| 100 mL in 1 bottle | 68788-4106-1 | Preferred Pharmaceuticals | 21 April 2026 |
| 100 mL in 1 bottle | 68788-8655-1 | Preferred Pharmaceuticals | 9 May 2024 |
| 100 mL in 1 bottle | 63187-616-00 | Proficient Rx | 8 May 2007 |
| 60 mL in 1 bottle | 63187-616-60 | Proficient Rx | 8 May 2007 |
| 100 mL in 1 bottle | 71205-380-00 | Proficient Rx | 3 June 2021 |
| 60 mL in 1 bottle | 71205-380-60 | Proficient Rx | 6 January 2020 |
| 1 bottle in 1 carton / 100 mL in 1 bottle | 71205-405-00 | Proficient Rx | 18 February 2020 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 71205-405-60 | Proficient Rx | 28 May 2020 |
| 100 mL in 1 bottle | 68071-3403-1 | NuCare Pharmaceuticals,Inc | 16 May 2023 |
| 60 mL in 1 bottle | 68071-5106-6 | NuCare Pharmaceuticals,Inc | 7 November 2019 |
| 100 mL in 1 bottle | 76420-328-01 | Asclemed | 19 April 2025 |
| 60 mL in 1 bottle | 76420-328-60 | Asclemed | 19 April 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 December 1997 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefdinir
Clinical summary
Cefdinir is a cephalosporin antibacterial indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. MedsAcross supplies Cefdinir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefdinirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- cefdinir prescribing information (Ascend Laboratories) · U.S. National Library of Medicine, DailyMed
Need Cefdinir 250 mg/5 mL powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.